Summary & Overview
HCPCS A9698: Non-Radioactive Contrast Imaging Material, Per Study
HCPCS Level II code A9698 identifies non-radioactive contrast imaging material used on a per-study basis when no specific HCPCS code applies. This designation is important for billing clarity and reimbursement for contrast agents that lack a more specific product-level code. Nationwide, accurate use of A9698 affects claim processing for outpatient imaging services at hospitals, ambulatory imaging centers, and other diagnostic settings.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role, typical sites of service, and how it is applied in claims. The publication outlines common billing modifiers associated with contrast administration (listed in the metadata) and notes where data is not available in the input. It also summarizes policy and coverage considerations relevant to payers and highlights areas where coders and billing staff should confirm payer-specific guidance.
This brief provides national context rather than state-level rules, enabling providers and billing professionals to understand when A9698 is used, which payers commonly encounter it, and what supporting information is typically required for claim adjudication.
Billing Code Overview
HCPCS Level II code A9698 describes non-radioactive contrast imaging material, not otherwise classified, per study. This code covers contrast agents used to enhance imaging studies when the product does not fit a more specific HCPCS descriptor.
-
Service type: Imaging contrast agent administration for diagnostic imaging studies
-
Typical site of service: Hospital outpatient departments, ambulatory imaging centers, and other outpatient diagnostic settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred for a specialized imaging study requiring a non-radioactive contrast agent not otherwise classified, billed with A9698. Example scenario: a 58-year-old patient with chronic peripheral arterial disease and severe iodinated-contrast allergy undergoes non-iodinated, non-radioactive contrast-enhanced vascular imaging (for example, CO2 or gadolinium alternatives used off-label for peripheral angiography) to evaluate limb ischemia. The workflow includes pre-procedure assessment (allergy review, renal function evaluation), informed consent, intravenous or intra-arterial administration of the non-radioactive contrast per institutional protocol, real-time fluoroscopic or digital subtraction angiography acquisition, immediate post-procedure monitoring for adverse reactions, and documentation of the specific agent and volume used. Typical indications include diagnostic vascular studies when standard iodinated contrast is contraindicated, endovascular procedure planning, or follow-up imaging when MRI contrast cannot be used. Typical site of service is an outpatient hospital radiology suite, ambulatory surgical center, or an inpatient interventional radiology or vascular surgery suite depending on acuity and setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to administer the contrast is substantially greater than typical (document justification). |